RENB-DC-11 / Renovaro Biosci - LARVOL DELTA

GEDi Cube and Renovaro Biosciences sign definitive merger agreement [Google translation] (Businesswire) - "GEDi Cube Intl Ltd...and Renovaro Biosciences Inc...have signed an definitive merger agreement, pursuant to which GEDi Cube will become an exclusive subsidiary of Renovaro through an acquisition by exchange of shares (the 'Transaction')....Renovaro Biosciences has developed advanced cell, gene and immunotherapy techniques designed to revive the body's natural anti-tumor capabilities. The company plans to begin Phase 1/2 human clinical trials for its lead candidate for pancreatic cancer and other solid tumors with low life expectancy by the second half of 2024."

M&A • Gastrointestinal Cancer • Oncology • Pancreatic Cancer • Solid Tumor